Medical therapy, refractory chronic rhinosinusitis, and productivity costs.

Abstract

PURPOSE OF REVIEW The purpose of this review is to address the most recent advances in the medical therapy for chronic rhinosinusitis (CRS), define recalcitrant and refractory CRS, and discuss the productivity costs associated with CRS. RECENT FINDINGS Recent studies evaluating anti-IL-4 receptor α antibodies and calcium channel blockers have demonstrated… (More)
DOI: 10.1097/ACI.0000000000000329

Topics

3 Figures and Tables

Slides referencing similar topics